Figure 4

![Figure 4: Mechanisms by which ALC may slow cognitive decline are depicted, including neuroprotection, neurotransmitter modulation, and mitochondrial support in the context of Alzheimer's disease and mild cognitive impairment.]()

> Source: Manuela Pennisi et al. "Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update.." *Nutrients*, 2020. PMID: [32408706](https://pubmed.ncbi.nlm.nih.gov/32408706/)

<figure>
  <img src="" alt="Mechanisms by which ALC may slow cognitive decline are depicted, including neuroprotection, neurotransmitter modulation, and mitochondrial support in the context of Alzheimer's disease and mild cognitive impairment." />
  <figcaption>Figure 4. Mechanisms by which ALC may slow cognitive decline are depicted, including neuroprotection, neurotransmitter modulation, and mitochondrial support in the context of Alzheimer's disease and mild cognitive impairment.<br>  Source: Manuela Pennisi et al. "Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update.." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32408706/">32408706</a></figcaption>
</figure>